ArticleActa biochimica Polonica2025
An analysis of epidemiological characteristics of microvascular complications and comorbidities among type 1 diabetes patients.
Article in Acta biochimica Polonica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The effects of GLP-1 agonists on HbA1c and insulin dose among patients with type 1 diabetes.Frontiers in endocrinology · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Epidemiological analysis of medical data of patients with type 1 diabetes (T1DM) and disease complications treated in hospital. Methods: A retrospective, cross-sectional study was conducted on records from 306 patients with type 1 diabetes (180 men and 126 women). The study analyzed demographic, clinical, and biological data, focusing on associations between Hashimoto's disease, neuropathy, and retinopathy using k-means clustering. Results: Hypertension was present in 28.8%, Hashimoto's disease in 17.6%, retinopathy in 17.6%, neuropathy in 8.2%. Multivariate logistic regression showed that the chance of retinopathy more than doubles with the coexistence of hypertension (OR 2.096, 95% Cl: 1.035-4.248) and this chance increases by 4.5% with each year of age compared to the previous year (OR 1.045, 95% Cl: 1.011-1.080). The risk of neuropathy increases by 10.8% with each year since diabetes diagnosis compared to the previous year (OR = 1.108, 95% Cl: 1.062-1.156) and the chance of this disease rises by 17.6% with each year of diabetes duration compared to the previous year (OR 1.176, 95% Cl: 1.092-1.267). Clustering was strongest in patients without comorbidities (66.3%). Only 2.3% had Hashimoto's disease and retinopathy, 3.59% had retinopathy and neuropathy, and just 1.3% had all three conditions. Conclusion: Patient age, duration of diabetes, and the presence of hypertension are key risk factors for diabetes-related complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.